Responses of state Medicaid programs to buprenorphine diversion: doing more harm than good?

JAMA Intern Med. 2013 Sep 23;173(17):1571-2. doi: 10.1001/jamainternmed.2013.9059.

Authors

Robin E Clark¹, Jeffrey D Baxter

Affiliation

¹ Department of Family Medicine and Community Health, University of Massachusetts Medical School, Shrewsbury2Center for Health Policy and Research, University of Massachusetts Medical School, Shrewsbury3Department of Quantitative Health Sciences, University of Massachusetts Medical School, Shrewsbury.

PMID: 23877740
DOI: 10.1001/jamainternmed.2013.9059

No abstract available

Publication types

Review

MeSH terms

Buprenorphine / economics
Buprenorphine / therapeutic use*
Humans
Medicaid / economics*
Opiate Substitution Treatment / economics*
Opioid-Related Disorders / drug therapy*
Opioid-Related Disorders / economics
United States

Substances

Buprenorphine